| Name | TNG-462 |
|---|
| Description | TNG-462 (Compound 1143) is an orally active PRMT5 inhibitor for investigation of MTAP-deficient and/or MTA-accumulating cancers[1]. |
|---|---|
| Related Catalog | |
| Target |
PRMT5[1]. |
| References |
| Molecular Formula | C28H36N6O2S |
|---|---|
| Molecular Weight | 520.69 |